Noritaka Kawada

Author PubWeight™ 17.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 2009 3.13
2 The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J Am Soc Nephrol 2009 1.95
3 Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002 1.37
4 Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. J Biol Chem 2006 1.24
5 Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis 2010 1.10
6 Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun 2012 1.05
7 Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats. Nephrol Dial Transplant 2009 1.00
8 Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy. Clin Exp Nephrol 2012 0.99
9 Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 2003 0.95
10 A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med 2011 0.86
11 Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. Am J Physiol Heart Circ Physiol 2007 0.84
12 CCAAT/Enhancer-binding protein delta contributes to myofibroblast transdifferentiation and renal disease progression. J Am Soc Nephrol 2004 0.82
13 Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics. Clin Exp Nephrol 2008 0.79
14 Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease. Clin Exp Nephrol 2011 0.77
15 Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant 2010 0.77
16 Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients. Clin Exp Nephrol 2011 0.75